POSTERS AND ABSTRACTS FOR:
American Society of Clinical Oncology | ASCO
2017
Comprehensive genomic profiling to merge precision medicine with immunotherapy
Tumor mutation burden derived from large NGS panel as biomarker for immunotherapy response
2016
2015
An End-to-End Precision Medicine Approach for Matching Cancer Patients to Clinical Trials
CANCERPLEX TEST
- Eifert C, Pantazi A , Sun R, Xu J, Cingolani P, Heyer J, Russell M, Lvova M, Ring J, Tse J, Lyle S, Protopopov A. Clinical application of a cancer genomic profiling assay to guide precision medicine decisions. PERSONALIZED MEDICINE. Vol.14,NO.4
- Shimada, Y., Yagi, R., Kameyama, H., Nagahashi, M., Ichikawa, H., Tajima, Y., . . . Wakai, T. (2017). Utility of comprehensive genomic sequencing for detecting HER2-positive colorectal cancer. HUMAN PATHOLOGY,66, 1-9. doi:10.1016/j.humpath.2017.02.004
- Nagahashi M, Wakai T, Shimada Y, Ichikawa H, Kameyama H, Kobayashi T, Nakajima M, Muneoka Y, Akazawa K, Moro K, Tsuchida J, Soma D, Yuza K, Ando T, Izutsu H, Tse J, Okuda S, Takabe K, Protopopov A, Lyle S. Mutation burden and microsatellite instability in colorectal cancer in Japan and US. Journal of Clinical Oncology. 2016;34(suppl): abstr e15103.
- Ichikawa H, Shimada Y, Nagahashi M, Kameyama H, Sakata J, Okamura T, Tajima Y, Yagi R, Sato N, Takii S, Maruyama S, Nogami H, Honma K, Kawasaki T, Inada T, Okuda S, Protopopov A, Lyle S, Takabe K, Wakai T. Large panel genomic profiling using CancerPlex to reveal candidates for HER2 targeted therapies in colorectal cancer. Journal of Clinical Oncology. 2016;34(suppl): e13125.
- Wakai T, Nagahashi M, Shimada Y, Ichikawa H, Kameyama H, Kobayashi T, Sakata J, Sato N, Izutsu H, Kodama K, Nakada M, Russell M, Heyer J, Powers W, Sun R, Ring J, Okuda S, Takabe K, Protopopov A, Lyle S. Large-scale genomic sequencing of colorectal cancer in the Japanese population. Journal of Clinical Oncology. 2016;34 (suppl): abstr e15121.
- Jiang J, Eifert C, Lyle S, Protopopov A, Sun R, Pantazi A, Heyer J, Russell M. Clinical next generation sequencing in lung cancer: Beyond personalized medicine. Journal of Clinical Oncology. 2016; 34 (suppl): abstr e23128.
- Lyle S, Powers W, Xu J, Huettner C, Russell M, Protopopov A. Comparison of a large NGS panel to hot-spot testing and small panels for the ability to accurately stratify advanced colorectal cancer patients to appropriate treatment pathways. Journal of Clinical Oncology. 2016; 34 (suppl): abstr 510.
- Protopopov A, Xu J, Huettner C, Russell M, Schell S, Lyle S. An end-to-end precision medicine approach for matching cancer patients to clinical trials. Journal of Clinical Oncology. 2015; 33(suppl): abstr e17508.
- Lyle S, Xu J, Huettner C, Schell S, Russell M, Protopopov A. Clinical utilization and performance characteristics of large NGS gene panel in the community practice setting. Journal of Clinical Oncology. 2015;33(suppl):abstr e17508.